AMPK - activated protein kinase and its role in energy metabolism of the heart

Current Cardiology Reviews

Volumn 6, Issue 4, 2010, Pages 337-342

  Heidrich, Florian ^a   Schotola, Hanna ^a   Popov, Aron F ^a   Sohns, Christian ^a   Schuenemann, Julia ^a   Friedrich, Martin ^a   Coskun, Kasim O ^a   von Lewinski, Dirk ^b   Hinz, Jose ^a   Bauer, Martin ^a   Mokashi, Suyog A ^c   Sossalla, Samuel ^a   Schmitto, Jan D ^a,c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adenosine monophosphate activated protein kinase; AMPK; Cardiac energy metabolism; Heart failure

Indexed keywords

ADENOSINE MONOPHOSPHATE ACTIVATED KINASE; ADENOSINE PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; ENERGY METABOLISM; ENZYME ACTIVITY; FATTY ACID METABOLISM; GLUCOSE METABOLISM; HEART FAILURE; HEART MUSCLE METABOLISM; HEART PROTECTION; HEART STRESS; HEART VENTRICLE REMODELING; PHOSPHORYLATION AND DEPHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 78651276109     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340310793566073     Document Type: Article

References (37)

1. Carlson CA, Kim KH. Regulation of hepatic acetyl coenzyme Acarboxylase by phosphorylation and dephosphorylation. J BiolChem 1973; 248(1): 378-80.
2. Reuben JS, Kosmatka M, Bardeesy N, et al. The tumor suppressorLKB1 kinase directly activates AMP-activated kinase and regulatesapoptosis in response to energy stress. Proc Natl Acad Sci USA 2004; 101(10): 3329-35.
3. Arad M, Seidman CE, Seidman JG. AMP-activated protein kinasein the heart: role during health and disease. Circ Res 2007; 100(4): 474-88.
4. Dyck JR, Lopaschuk GD. AMPK alterations in cardiac physiologyand pathology: enemy or ally? J Physiol 2006; 574(Pt 1): 95-112.
5. Allard MF, Parsons HL, Saeedi R, Wambolt RB, Brownsey R. AMPK and metabolic adaptation by the heart to pressure overload. Am J Physiol Heart Circ Physiol 2007; 292(1): H140-8.
6. Schmitto JD, Ortmann P, Kolat P, et al. Chronic heart failure inducedby multiple sequential microembolization in a sheep model. Int J Artif Organs 2008; 31(4): 348-53.
7. Schmitto JD, Ortmann P, Vorkamp T, et al. Histological changes ina model of chronic heart failure induced by multiple sequentialcoronary microembolization in sheep J Cardiovasc Surg (Torino) 2008; 49(4): 533-7.
8. Schmitto JD, Coskun KO, Coskun ST, et al. Hemodynamicchanges in a model of chronic heart failure induced by multiple sequentialcoronary microembolization in sheep. Artif Organs 2009; 33(11): 947-52.
9. Schmitto JD, Mokashi SA, Lee LS, et al. Large animal models ofchronic heart failure. J Surg Res 2009 Epub ahead of print].
10. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA. The Ca2+/calmodulin-dependent protein kinasekinases are AMP-activated protein kinase kinases. J Biol Chem 2005; 280(32): 29060-6.
11. Carvajal K, Zarrinpashneh E, Szarszoi O, et al. Dual cardiac contractileeffects of the alpha2-AMPK deletion in low-flow ischemiaand reperfusion. Am J Physiol Heart Circ Physiol 2007; 292(6): H3136-47.
12. Miller EJ, Li J, Leng L, et al. Macrophage migration inhibitoryfactor stimulates AMP-activated protein kinase in the ischaemicheart. Nature 2008; 451(7178): 578-82.
13. Hardie DG, Hawley SA, Scott JW. AMP-activated protein kinase -development of the energy sensor concept. J Physiol 2006; 574(Pt1): 7-15.
14. Yatscoff MA, Jaswal JS, Grant MR, et al. Myocardial hypertrophyand the maturation of fatty acid oxidation in the newborn humanheart. Pediatr Res 2008; 64(6): 643-7.
15. Athéa Y, Viollet B, Mateo P, et al. AMP-activated protein kinasealpha2 deficiency affects cardiac cardiolipin homeostasis and mitochondrialfunction. Diabetes 2007; 56(3): 786-94.
16. Ofir M, Arad M, Porat E, et al. Increased glycogen stores due togamma-AMPK overexpression protects against ischemia and reperfusiondamage. Biochem Pharmacol 2008; 75(7): 1482-91.
17. Candia AM, Villacorta H Jr, Mesquita ET. Immune-inflammatoryactivation in heart failure. Arq Bras Cardiol 2007; 89(3): 183-90,201-8. Review
18. Neumann FJ, Ott I, Gawaz M, et al. Cardiac release of cytokinesand inflammatory responses in acute myocardial infarction. Circulation 1995; 92(4): 748-55.
19. Miller EJ, Li J, Leng L, et al. Macrophage migration inhibitoryfactor stimulates AMP-activated protein kinase in the ischaemicheart. Nature 2008; 451(7178): 578-82.
20. Borutaite V. AMPK, MAPK and Bax in the heart: some questionsanswered. Biochem J 2008; 412(2): e15-6.
21. Zhao X, Zmijewski JW, Lorne E, et al. Activation of AMPK attenuatesneutrophil proinflammatory activity and decreases the severityof acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008; 295(3): L497-504.
22. Takagi H, Matsui Y, Hirotani S, Sakoda H, Asano T, Sadoshima J. AMPK mediates autophagy during myocardial ischemia in vivo. Circ Res 2007; 100(6): 914-22.
23. Matsui Y, Takagi H, Qu X, et al. Distinct roles of autophagy in theheart during ischemia and reperfusion: roles of AMP-activated proteinkinase and Beclin 1 in mediating autophagy. Circ Res 2007; 100(6): 914-22.
24. Mount PF, Hill RE, Fraser SA, et al. Acute renal ischemia rapidlyactivates the energy sensor AMPK but does not increase phosphorylationof eNOS-Ser1177. Am J Physiol Renal Physiol 2005; 289(5): F1103-15.
25. Terai K, Hiramoto Y, Masaki M, et al. AMP-activated proteinkinase protects cardiomyocytes against hypoxic injury through attenuationof endoplasmic reticulum stress. Mol Cell Biol 2005; 25(21): 9554-75.
26. Jaswal JS, Gandhi M, Finegan BA, Dyck JR, Clanachan AS. Effectsof adenosine on myocardial glucose and palmitate metabolismafter transient ischemia: role of 5'-AMP-activated protein kinase. Am J Physiol Heart Circ Physiol 2006; 291(4): H1883-92.
27. Du J, Guan T, Zhang H, Xia Y, Liu F, Zhang Y. Inhibitory crosstalkbetween ERK and AMPK in the growth and proliferation ofcardiac fibroblasts. Biochem Biophys Res Commun 2008; 368(2): 402-7.
28. Luptak I, Shen M, He H, et al. Aberrant activation of AMPactivatedprotein kinase remodels metabolic network in favor ofcardiac glycogen storage. J Clin Invest 2007; 117(5): 1432-9.
29. Baron SJ, Li J, Russell RR 3rd, et al. Dual mechanisms regulatingAMPK kinase action in the ischemic heart. Circ Res 2005; 96(3): 337-45.
30. Russell RR 3rd, Li J, Coven DL, et al. AMP-activated proteinkinase mediates ischemic glucose uptake and preventspostischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 2004; 114(4): 495-503.
31. Wong AK, Howie J, Petrie JR, Lang CC. AMP-activated proteinkinase pathway: a potential therapeutic target in cardiometabolicdisease. Clin Sci (Lond) 2009; 116(8): 607-20.
32. Schmitto JD, Heidrich F, Schotola H, et al. The role of phospho-AMPK and VEGF in a model of chronic heart failure. submitted toArtif Organs 2010.
33. Doenst T, Amorim PA. Metabolic therapy in cardiac surgery -"Optimizing the engine's fuel supply and more..." Scand Cardiovasc J 2010; 44(1): 4-8.
34. Hardie DG. Role of AMP-activated protein kinase in the metabolicsyndrome and in heart disease. FEBS Lett 2008; 582(1): 81-9.
35. Wang Y, Gao E, Tao L, et al. AMP-activated protein kinase deficiencyenhances myocardial ischemia/reperfusion injury but hasminimal effect on the antioxidant/antinitrative protection of adiponectin. Circulation 2009; 119(6): 835-44.
36. Tzoulaki I, Molokhia M, Curcin V, et al. Risk of cardiovasculardisease and all cause mortality among patients with type 2 diabetesprescribed oral antidiabetes drugs: retrospective cohort study usingUK general practice research database. BMJ 2009; 339: b4731.
37. Lopaschuk GD. AMP-activated protein kinase control of energymetabolism in the ischemic heart. Int J Obes (Lond) 2008; 32(Suppl 4): S29-35.